Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAVID: Vitamin D3 in NSTEMI
NCT03405207Phase 2Unknown
- Start
- May 2018
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vitamin d in Vitamin D deficiency (VDD) (2 arms). Primary endpoint: Endothelial function change from baseline at 8 weeks. Status: unknown.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT03405207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03405207.